Cite
HARVARD Citation
Avouac, J. et al. (n.d.). SAT0163 Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory rheumatic diseases in daily clinical practice: the experience of cochin hospital, paris, france. Annals of the rheumatic diseases. pp. 831-832. [Online].